Table 3.
Cumulative PCR tests in 360-day period, n |
Highest daily resource use during the 360-day period, n |
|||||
---|---|---|---|---|---|---|
PCR tests | Hospital beds (non-ICU) | ICU beds* | Isolation centre beds | Quarantine centre beds | ||
Re 1·5 | ||||||
Health-care testing alone | 1 527 450 | 14 820 | 4690 | 748 | .. | .. |
Health-care testing, contact tracing, isolation centres, mass symptom screening, and quarantine centres† | 3 904 230 | 12 900 | 640 | 341 | 12 380 | 18 140 |
Health-care testing and contact tracing | 5 951 180 | 31 050 | 3440 | 748 | .. | .. |
Health-care testing, contact tracing, isolation centres, and mass symptom screening | 4 639 280 | 16 930 | 1320 | 715 | 21 260 | .. |
Health-care testing, contact tracing, and isolation centres | 4 904 010 | 19 340 | 1930 | 748 | 30 510 | .. |
Health-care testing, contact tracing, isolation centres, and quarantine centres | 4 478 770 | 16 710 | 1380 | 737 | 26 710 | 39 470 |
Re 1·2 | ||||||
Health-care testing, contact tracing, isolation centres, and quarantine centres† | 2 963 280 | 9870 | 590 | 363 | 1840 | 3110 |
Health-care testing, contact tracing, and isolation centres | 3 025 260 | 9870 | 590 | 363 | 1620 | .. |
Health-care testing, contact tracing, isolation centres, and mass symptom screening | 3 159 950 | 10 520 | 570 | 396 | 1510 | .. |
Health-care testing, contact tracing, isolation centres, mass symptom screening, and quarantine centres | 3 120 800 | 10 520 | 570 | 396 | 1860 | 3480 |
Health-care testing and contact tracing | 3 647 570 | 12 450 | 770 | 506 | .. | .. |
Health-care testing alone | 766 140 | 4440 | 1680 | 748 | .. | .. |
Strategies are listed in order of ascending costs. ICU=intensive care unit. Re=effective reproductive number.
748 ICU beds available in total.
The cost-effective strategy in this scenario.